Triple Combination Chemotherapy Effective For Advanced Colorectal Cancer, Trial Finds
Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval
Liver Transplants Extend Survival In Early-Stage Cancer
Trimodality Therapy Improves Survival In Early Disease
NCI Encourages IP Chemo For Stage III Ovarian Cancer
Study Finds No Evidence That Statins Cut Cancer Risk
Chest X-Ray Produces Many False-Positive Results
NMP22 Assay More Effective Than Conventional Lab Test
Chemotherapy After Surgery Extends Survival By 32%
Some Tumors Show Partial Response To Drug Combo
Recombinant TSH Avoids Need To Stop Replacement Therapy
Partial Responses To Zactima In Thyroid Cancer Trial
NCI-Approved Clinical Trials
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- How will FDA regulate psychedelics?
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Cancer hospitals brace for impact, as CMS moves to slash 340B payments by 33%
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - The future of oncology: Early-career scientists need mentorship and a new academic model
